WallStreetZenWallStreetZen

NASDAQ: VIR
VIR BIOTECHNOLOGY INC Stock Forecast, Predictions & Price Target

Analyst price target for VIR

Based on 6 analysts offering 12 month price targets for VIR BIOTECHNOLOGY INC.
Min Forecast
$28.00+22.7%
Avg Forecast
$59.67+161.47%
Max Forecast
$125.00+447.77%

Should I buy or sell VIR stock?

Based on 6 analysts offering ratings for VIR BIOTECHNOLOGY INC.
Buy
Strong Buy
1 analysts 16.67%
Buy
2 analysts 33.33%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

VIR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 7%
7
BuyMaintains$125.00+447.77%2022-05-12
Needham
Bottom 6%
6
BuyMaintains$35.00+53.37%2022-05-06
Baird
Top 19%
82
HoldUpgrades$28.00+22.70%2022-03-03
JP Morgan
Bottom 2%
2
HoldUpgrades$37.00+62.14%2021-10-25
Goldman Sachs
Bottom 12%
12
HoldDowngrades$62.00+171.69%2021-09-22
Barclays
Top 20%
81
Strong BuyMaintains$71.00+211.13%2021-08-06

1 of 1

Forecast return on equity

Is VIR forecast to generate an efficient return?
Company
-2.71%
Industry
75.03%
Market
30.81%
VIR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VIR forecast to generate an efficient return on assets?
Company
-1.88%
Industry
20.33%
VIR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VIR earnings per share forecast

What is VIR's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$2.16-76.77%
Avg 2 year Forecast
-$2.72-129.25%
Avg 3 year Forecast
-$0.71-107.63%

VIR revenue forecast

What is VIR's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.5B-35.05%
Avg 2 year Forecast
$223.0M-90.41%
Avg 3 year Forecast
$486.8M-79.07%
VIR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VIR revenue growth forecast

How is VIR forecast to perform vs Biotechnology companies and vs the US market?
Company
-40.63%
Industry
17.61%
Market
8.93%
VIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VIR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VIR$22.82$59.67+161.47%Buy
CERT$18.61$27.75+49.11%Strong Buy
KRTX$105.41$172.00+63.17%Strong Buy
DNLI$23.25$96.33+314.34%Strong Buy
ABCM$13.98$21.00+50.21%Buy

VIR BIOTECHNOLOGY Stock Forecast FAQ

Is VIR BIOTECHNOLOGY Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: VIR) stock is to Buy VIR stock.

Out of 6 analysts, 1 (16.67%) are recommending VIR as a Strong Buy, 2 (33.33%) are recommending VIR as a Buy, 3 (50%) are recommending VIR as a Hold, 0 (0%) are recommending VIR as a Sell, and 0 (0%) are recommending VIR as a Strong Sell.

What is VIR's earnings growth forecast for 2022-2024?

(NASDAQ: VIR) VIR BIOTECHNOLOGY's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.77%.

VIR BIOTECHNOLOGY's earnings in 2022 is $1,216,116,000.On average, 3 Wall Street analysts forecast VIR's earnings for 2022 to be $285,931,510, with the lowest VIR earnings forecast at $225,038,688, and the highest VIR earnings forecast at $407,717,153. On average, 3 Wall Street analysts forecast VIR's earnings for 2023 to be -$360,061,901, with the lowest VIR earnings forecast at -$430,221,022, and the highest VIR earnings forecast at -$254,161,342.

In 2024, VIR is forecast to generate -$93,986,746 in earnings, with the lowest earnings forecast at -$93,986,746 and the highest earnings forecast at -$93,986,746.

What is VIR's revenue growth forecast for 2022-2024?

(NASDAQ: VIR) VIR BIOTECHNOLOGY's forecast annual revenue growth rate of -40.63% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 17.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.93%.

VIR BIOTECHNOLOGY's revenue in 2022 is $2,325,890,000.On average, 1 Wall Street analysts forecast VIR's revenue for 2022 to be $199,966,730,909, with the lowest VIR revenue forecast at $199,966,730,909, and the highest VIR revenue forecast at $199,966,730,909. On average, 1 Wall Street analysts forecast VIR's revenue for 2023 to be $29,519,780,877, with the lowest VIR revenue forecast at $29,519,780,877, and the highest VIR revenue forecast at $29,519,780,877.

In 2024, VIR is forecast to generate $64,440,490,273 in revenue, with the lowest revenue forecast at $64,440,490,273 and the highest revenue forecast at $64,440,490,273.

What is VIR's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: VIR) forecast ROA is -1.88%, which is lower than the forecast US Biotechnology industry average of 20.33%.

What is VIR's Price Target?

According to 6 Wall Street analysts that have issued a 1 year VIR price target, the average VIR price target is $59.67, with the highest VIR stock price forecast at $125.00 and the lowest VIR stock price forecast at $28.00.

On average, Wall Street analysts predict that VIR BIOTECHNOLOGY's share price could reach $59.67 by May 12, 2023. The average VIR BIOTECHNOLOGY stock price prediction forecasts a potential upside of 161.47% from the current VIR share price of $22.82.

What is VIR's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: VIR) VIR BIOTECHNOLOGY's current Earnings Per Share (EPS) is $9.30. On average, analysts forecast that VIR's EPS will be $2.16 for 2022, with the lowest EPS forecast at $1.70, and the highest EPS forecast at $3.08. On average, analysts forecast that VIR's EPS will be -$2.72 for 2023, with the lowest EPS forecast at -$3.25, and the highest EPS forecast at -$1.92. In 2024, VIR's EPS is forecast to hit -$0.71 (min: -$0.71, max: -$0.71).

What is VIR's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: VIR) forecast ROE is -2.71%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.